Djokovic buys 80% in Danish biotech Develi'nin COVID-19 treatment

Summary by Ground News

Tennis champion Novak Djokovic has an 80% stake of Danish biotech firm QuantBioRes. The company is aiming to develop a medical treatment to counter COVID-19. CEO Ivan Loncarevic, who described himself as an entrepreneur, said the investment was made in June 2020.

4 months ago·B G, Serbia

News Articles

Times of India

Djokovic holds 80% of Danish biotech developing COVID treatment: CEO

Off the field News: Tennis champion Novak Djokovic has an 80% stake of Danish biotech firm QuantBioRes, which is aiming to develop a medical treatment to counter COVID-19

4 months ago·Mumbai, India

Read Full Article

BBC News

Novak Djokovic is the majority shareholder of a biotech company seeking a treatment for covid that does not require a vaccine - BBC News World

The number one in world tennis owns 80% of the company, which is looking for a cure for covid-19.

4 months ago·United Kingdom

Read Full Article

Reuters

Djokovic buys 80% in Danish biotech developing COVID-19 treatment

COPENHAGEN - Tennis player Novak Djokovic has purchased 80% of Danish biotech firm QuantBioRes, aiming to develop a medical treatment against COVID-19, the company's chief executive told Reuters. (Reporting by Nikolaj Skydsgaard; Editing by Alison Williams)

4 months ago·United Kingdom

Read Full Article

The Guardian

Djokovic has 80% stake in biotech firm developing Covid drug

QuantBioRes is working on a treatment not a vaccine, but CEO says tennis star is ‘not anti-vax’

4 months ago·London, United Kingdom

Read Full Article

CTV News

Novak Djokovic holds 80 per cent of Danish biotech developing COVID-19 treatment: CEO

Tennis champion Novak Djokovic has an 80 per cent stake of Danish biotech firm QuantBioRes, which is aiming to develop a medical treatment to counter COVID-19, the company's chief executive told Reuters on Wednesday.

4 months ago·Toronto, Canada

Read Full Article

NDTV

Novak Djokovic Holds Major Stake In Firm Developing Covid Drug: CEO

Serbian tennis star Novak Djokovic, recently deported from Australia due to his coronavirus vaccine status, is co-founder and majority shareholder of a biotech firm developing a Covid treatment, the Danish company's CEO said Wednesday.

4 months ago·New Delhi, India

Read Full Article